Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 21.40B | 20.62B | 19.15B | 17.58B | 13.03B |
Gross Profit | 14.32B | 13.95B | 13.11B | 11.58B | 7.45B |
EBITDA | 6.53B | 6.53B | 6.19B | 5.43B | 3.04B |
Net Income | 2.75B | 2.36B | 313.00M | 2.07B | 1.30B |
Balance Sheet | |||||
Total Assets | 41.01B | 42.68B | 40.99B | 40.21B | 35.79B |
Cash, Cash Equivalents and Short-Term Investments | 16.77B | 19.49B | 18.38B | 16.60B | 13.43B |
Total Debt | 13.15B | 16.36B | 15.75B | 15.13B | 13.59B |
Total Liabilities | 18.84B | 22.05B | 21.92B | 20.23B | 17.90B |
Stockholders Equity | 22.10B | 20.54B | 19.01B | 19.92B | 17.77B |
Cash Flow | |||||
Free Cash Flow | 3.26B | 3.67B | 3.37B | 3.95B | 2.68B |
Operating Cash Flow | 4.44B | 4.70B | 4.31B | 4.87B | 3.19B |
Investing Cash Flow | -1.55B | -2.56B | -1.97B | -2.47B | -2.18B |
Financing Cash Flow | -2.55B | -1.82B | -2.25B | -1.78B | 898.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $106.05B | 40.84 | 17.53% | 1.78% | 2.71% | 10.20% | |
75 Outperform | $3.85B | 31.42 | 6.82% | 1.32% | -1.63% | -72.22% | |
63 Neutral | $808.32M | ― | -8.75% | ― | 7.08% | -42.22% | |
61 Neutral | $17.92B | 12.81 | -0.76% | 2.98% | 1.30% | -14.28% | |
60 Neutral | $21.68B | 126.52 | 9.76% | 1.38% | 5.09% | -80.06% | |
58 Neutral | $999.11M | ― | 32.94% | ― | 12.68% | 62.96% | |
50 Neutral | $2.53B | ― | -142.38% | ― | -16.69% | -279.61% |